Rayyan Zafar has previously completed undergraduate studies in BSc Biomedical Sciences at Newcastle University (1st Class Hons) and an MSc in Clinical Neuropsychiatry from Kings College London, IOPPN (Distinction). He is currently undertaking his Ph.D. at Imperial College after being awarded the Medical Research Council Doctoral Training 3.5 year fellowship (MRC DTP). As a member of the Centre for Psychedelic Research and Neuropsychopharmacology group, he is investigating the neurobiology of addiction using advanced multimodal neuroimaging and how psychedelic therapies may be used to treat individuals with these conditions. He is currently involved in setting up neuromechanistic and clinical research into the effects of psilocybin therapy in opiate and gambling disorders. In addition he is a research officer at the charity Drug Science conducting policy and scientific research in the medical cannabis and medical psychedelic space. He also advises to several psychedelic biotechs and clinical retreat centres.